CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...